0 XP   0   0   0

Albert David Limited
Buy, Hold or Sell?

Should you buy, hold or sell Albert David Limited?

I guess you are interested in Albert David Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Albert David Limited

Let's start. I'm going to help you getting a better view of Albert David Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Albert David Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Albert David Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Albert David Limited. The closing price on 2023-01-30 was INR544.45 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Albert David Limited Daily Candlestick Chart
Albert David Limited Daily Candlestick Chart
Summary









1. Valuation of Albert David Limited




Current price per share

INR544.45

2. Growth of Albert David Limited




Is Albert David Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$34.3m$30m$4.3m12.6%

How much money is Albert David Limited making?

Current yearPrevious yearGrowGrow %
Making money$4.3m$2.7m$1.6m37.2%
Net Profit Margin11.2%8.9%--

How much money comes from the company's main activities?

3. Financial Health of Albert David Limited




Comparing to competitors in the Drug Manufacturers - Major industry




  Industry Rankings (Drug Manufacturers - Major)  


Richest
#11 / 12

Most Revenue
#11 / 12

Most Profit
#10 / 12


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Albert David Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Albert David Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Albert David Limited to the Drug Manufacturers - Major industry mean.
  • A Net Profit Margin of 11.2% means that ₹0.11 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Albert David Limited:

  • The MRQ is 11.2%. The company is making a huge profit. +2
  • The TTM is 11.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.2%TTM11.2%0.0%
TTM11.2%YOY8.9%+2.3%
TTM11.2%5Y7.6%+3.6%
5Y7.6%10Y7.4%+0.2%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ11.2%10.8%+0.4%
TTM11.2%10.8%+0.4%
YOY8.9%14.8%-5.9%
5Y7.6%12.2%-4.6%
10Y7.4%11.9%-4.5%
1.1.2. Return on Assets

Shows how efficient Albert David Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Albert David Limited to the Drug Manufacturers - Major industry mean.
  • 8.8% Return on Assets means that Albert David Limited generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Albert David Limited:

  • The MRQ is 8.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.8%TTM8.8%0.0%
TTM8.8%YOY6.5%+2.3%
TTM8.8%5Y6.7%+2.0%
5Y6.7%10Y8.2%-1.5%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8%1.8%+7.0%
TTM8.8%2.3%+6.5%
YOY6.5%3.0%+3.5%
5Y6.7%3.0%+3.7%
10Y8.2%2.7%+5.5%
1.1.3. Return on Equity

Shows how efficient Albert David Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Albert David Limited to the Drug Manufacturers - Major industry mean.
  • 12.6% Return on Equity means Albert David Limited generated ₹0.13 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Albert David Limited:

  • The MRQ is 12.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.6%TTM12.6%0.0%
TTM12.6%YOY9.1%+3.6%
TTM12.6%5Y9.6%+3.0%
5Y9.6%10Y13.4%-3.8%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ12.6%2.5%+10.1%
TTM12.6%3.9%+8.7%
YOY9.1%4.4%+4.7%
5Y9.6%4.2%+5.4%
10Y13.4%4.0%+9.4%

1.2. Operating Efficiency of Albert David Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Albert David Limited is operating .

  • Measures how much profit Albert David Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Albert David Limited to the Drug Manufacturers - Major industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Albert David Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y6.7%-6.7%
5Y6.7%10Y6.8%-0.1%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%-29.7%
TTM-11.5%-11.5%
YOY-11.7%-11.7%
5Y6.7%12.0%-5.3%
10Y6.8%11.0%-4.2%
1.2.2. Operating Ratio

Measures how efficient Albert David Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • An Operation Ratio of 0.42 means that the operating costs are ₹0.42 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Albert David Limited:

  • The MRQ is 0.415. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.415. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.415TTM0.4150.000
TTM0.415YOY0.391+0.024
TTM0.4155Y0.935-0.520
5Y0.93510Y1.087-0.153
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4150.475-0.060
TTM0.4150.425-0.010
YOY0.3910.731-0.340
5Y0.9350.943-0.008
10Y1.0870.983+0.104

1.3. Liquidity of Albert David Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Albert David Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A Current Ratio of 2.33 means the company has ₹2.33 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Albert David Limited:

  • The MRQ is 2.330. The company is able to pay all its short-term debts. +1
  • The TTM is 2.330. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.330TTM2.3300.000
TTM2.330YOY2.775-0.445
TTM2.3305Y2.444-0.114
5Y2.44410Y2.090+0.355
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3301.824+0.506
TTM2.3301.800+0.530
YOY2.7751.807+0.968
5Y2.4441.305+1.139
10Y2.0901.218+0.872
1.3.2. Quick Ratio

Measures if Albert David Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Albert David Limited to the Drug Manufacturers - Major industry mean.
  • A Quick Ratio of 3.42 means the company can pay off ₹3.42 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Albert David Limited:

  • The MRQ is 3.418. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.418. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.418TTM3.4180.000
TTM3.418YOY3.898-0.479
TTM3.4185Y2.994+0.424
5Y2.99410Y2.119+0.876
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4181.248+2.170
TTM3.4181.200+2.218
YOY3.8981.151+2.747
5Y2.9940.836+2.158
10Y2.1190.750+1.369

1.4. Solvency of Albert David Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Albert David Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Albert David Limited to Drug Manufacturers - Major industry mean.
  • A Debt to Asset Ratio of 0.31 means that Albert David Limited assets are financed with 30.6% credit (debt) and the remaining percentage (100% - 30.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Albert David Limited:

  • The MRQ is 0.306. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.306. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.306TTM0.3060.000
TTM0.306YOY0.284+0.022
TTM0.3065Y0.308-0.001
5Y0.30810Y0.372-0.064
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3060.415-0.109
TTM0.3060.419-0.113
YOY0.2840.429-0.145
5Y0.3080.455-0.147
10Y0.3720.431-0.059
1.4.2. Debt to Equity Ratio

Measures if Albert David Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Albert David Limited to the Drug Manufacturers - Major industry mean.
  • A Debt to Equity ratio of 44.1% means that company has ₹0.44 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Albert David Limited:

  • The MRQ is 0.441. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.441. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.441TTM0.4410.000
TTM0.441YOY0.397+0.044
TTM0.4415Y0.447-0.005
5Y0.44710Y0.633-0.187
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4410.675-0.234
TTM0.4410.698-0.257
YOY0.3970.738-0.341
5Y0.4470.840-0.393
10Y0.6330.814-0.181

2. Market Valuation of Albert David Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Albert David Limited generates.

  • Above 15 is considered overpriced but always compare Albert David Limited to the Drug Manufacturers - Major industry mean.
  • A PE ratio of 8.61 means the investor is paying ₹8.61 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Albert David Limited:

  • The EOD is 8.813. Very good. +2
  • The MRQ is 8.606. Very good. +2
  • The TTM is 8.606. Very good. +2
Trends
Current periodCompared to+/- 
EOD8.813MRQ8.606+0.207
MRQ8.606TTM8.6060.000
TTM8.606YOY9.710-1.105
TTM8.6065Y11.495-2.889
5Y11.49510Y9.905+1.590
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD8.81373.229-64.416
MRQ8.60666.328-57.722
TTM8.60660.797-52.191
YOY9.71033.289-23.579
5Y11.49560.412-48.917
10Y9.90564.422-54.517
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Albert David Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Albert David Limited:

  • The MRQ is 5.405. Seems overpriced? -1
  • The TTM is 5.405. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ5.405TTM5.4050.000
TTM5.405YOY8.406-3.001
TTM5.4055Y12.902-7.498
5Y12.90210Y13.790-0.888
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ5.405-0.235+5.640
TTM5.4050.137+5.268
YOY8.4060.124+8.282
5Y12.9020.232+12.670
10Y13.7900.222+13.568

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Albert David Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A PB ratio of 1.09 means the investor is paying ₹1.09 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Albert David Limited:

  • The EOD is 1.112. Good. +1
  • The MRQ is 1.086. Good. +1
  • The TTM is 1.086. Good. +1
Trends
Current periodCompared to+/- 
EOD1.112MRQ1.086+0.026
MRQ1.086TTM1.0860.000
TTM1.086YOY0.880+0.206
TTM1.0865Y0.995+0.090
5Y0.99510Y1.071-0.076
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD1.1121.495-0.383
MRQ1.0861.439-0.353
TTM1.0861.890-0.804
YOY0.8802.460-1.580
5Y0.9951.972-0.977
10Y1.0712.221-1.150
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Albert David Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--61.48361.4830%37.819+63%33.802+82%54.409+13%
Book Value Growth--1.1441.1440%1.097+4%1.089+5%1.161-1%
Book Value Per Share--489.685489.6850%428.202+14%400.565+22%320.465+53%
Book Value Per Share Growth--1.1441.1440%1.097+4%1.089+5%1.161-1%
Current Ratio--2.3302.3300%2.775-16%2.444-5%2.090+12%
Debt To Asset Ratio--0.3060.3060%0.284+8%0.3080%0.372-18%
Debt To Equity Ratio--0.4410.4410%0.397+11%0.447-1%0.633-30%
Dividend Per Share--6.0206.0200%0.070+8447%6.966-14%6.567-8%
Dividend Per Share Growth--85.46885.4680%0.005+1888565%18.381+365%11.889+619%
Eps--61.77961.7790%38.799+59%39.617+56%39.575+56%
Eps Growth--1.5921.5920%1.155+38%1.358+17%1.465+9%
Free Cash Flow Per Share--51.31051.3100%61.289-16%47.372+8%44.452+15%
Free Cash Flow Per Share Growth--0.8370.8370%2.384-65%27.127-97%17.559-95%
Free Cash Flow To Equity Per Share--42.75942.7590%58.302-27%33.914+26%30.870+39%
Free Cash Flow To Equity Per Share Growth--0.7330.7330%7.393-90%2.483-70%111.840-99%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--501.847--------
Intrinsic Value_10Y_min--430.538--------
Intrinsic Value_1Y_max--51.205--------
Intrinsic Value_1Y_min--49.755--------
Intrinsic Value_3Y_max--153.151--------
Intrinsic Value_3Y_min--144.653--------
Intrinsic Value_5Y_max--254.257--------
Intrinsic Value_5Y_min--233.518--------
Net Profit Margin--0.1120.1120%0.089+26%0.076+48%0.074+52%
Operating Margin----0%-0%0.067-100%0.068-100%
Operating Ratio--0.4150.4150%0.391+6%0.935-56%1.087-62%
Pb Ratio1.112+2%1.0861.0860%0.880+23%0.995+9%1.071+1%
Pe Ratio8.813+2%8.6068.6060%9.710-11%11.495-25%9.905-13%
Peg Ratio--5.4055.4050%8.406-36%12.902-58%13.790-61%
Price Per Share544.450+2%531.650531.6500%376.750+41%397.720+34%332.994+60%
Price To Total Gains Ratio8.066+2%7.8767.8760%9.943-21%13.094-40%11.159-29%
Profit Growth--1.5921.5920%1.155+38%1.358+17%1.465+9%
Quick Ratio--3.4183.4180%3.898-12%2.994+14%2.119+61%
Return On Assets--0.0880.0880%0.065+35%0.067+30%0.082+6%
Return On Equity--0.1260.1260%0.091+39%0.096+31%0.134-6%
Revenue Growth--1.2671.2670%0.771+64%1.018+24%1.019+24%
Total Gains Per Share--67.50367.5030%37.890+78%40.768+66%60.977+11%
Total Gains Per Share Growth--1.7821.7820%1.018+75%1.582+13%2.198-19%
Usd Book Value--34374945.30034374945.3000%30058986.000+14%28118865.180+22%22495997.533+53%
Usd Book Value Change Per Share--0.7560.7560%0.465+63%0.416+82%0.669+13%
Usd Book Value Per Share--6.0236.0230%5.267+14%4.927+22%3.942+53%
Usd Dividend Per Share--0.0740.0740%0.001+8447%0.086-14%0.081-8%
Usd Eps--0.7600.7600%0.477+59%0.487+56%0.487+56%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.6310.6310%0.754-16%0.583+8%0.547+15%
Usd Free Cash Flow To Equity Per Share--0.5260.5260%0.717-27%0.417+26%0.380+39%
Usd Price Per Share6.697+2%6.5396.5390%4.634+41%4.892+34%4.096+60%
Usd Profit--4336770.9004336770.9000%2723589.000+59%2781044.760+56%2778093.033+56%
Usd Revenue--38561902.20038561902.2000%30436337.700+27%36595958.760+5%37272362.000+3%
Usd Total Gains Per Share--0.8300.8300%0.466+78%0.501+66%0.750+11%
 EOD+2 -3MRQTTM+0 -0YOY+26 -145Y+32 -910Y+29 -12

3.2. Fundamental Score

Let's check the fundamental score of Albert David Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-158.813
Price to Book Ratio (EOD)Between0-11.112
Net Profit Margin (MRQ)Greater than00.112
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.418
Current Ratio (MRQ)Greater than12.330
Debt to Asset Ratio (MRQ)Less than10.306
Debt to Equity Ratio (MRQ)Less than10.441
Return on Equity (MRQ)Greater than0.150.126
Return on Assets (MRQ)Greater than0.050.088
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Albert David Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose540.000
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets4,028,414
Total Liabilities1,233,703
Total Stockholder Equity2,794,711
 As reported
Total Liabilities 1,233,703
Total Stockholder Equity+ 2,794,711
Total Assets = 4,028,414

Assets

Total Assets4,028,414
Total Current Assets2,538,313
Long-term Assets2,538,313
Total Current Assets
Cash And Cash Equivalents 22,762
Short-term Investments 1,725,339
Net Receivables 250,664
Inventory 405,861
Other Current Assets 34,519
Total Current Assets  (as reported)2,538,313
Total Current Assets  (calculated)2,439,145
+/- 99,168
Long-term Assets
Property Plant Equipment 846,205
Intangible Assets 38,679
Long-term Assets  (as reported)0
Long-term Assets  (calculated)884,884
+/- 884,884

Liabilities & Shareholders' Equity

Total Current Liabilities1,089,432
Long-term Liabilities-
Total Stockholder Equity2,794,711
Total Current Liabilities
Short-term Debt 37,657
Total Current Liabilities  (as reported)1,089,432
Total Current Liabilities  (calculated)37,657
+/- 1,051,775
Long-term Liabilities
Long term Debt Total 11,094
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)11,094
+/- 11,094
Total Stockholder Equity
Common Stock57,072
Retained Earnings 2,628,855
Capital Surplus 31,472
Other Stockholders Equity 77,312
Total Stockholder Equity (as reported)2,794,711
Total Stockholder Equity (calculated)2,794,711
+/-0
Other
Cash and Short Term Investments 1,748,101
Common Stock Shares Outstanding 5,707
Liabilities and Stockholders Equity 4,028,414



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
1,979,982
1,934,530
2,238,423
2,845,288
2,897,448
2,946,129
3,202,168
3,414,019
4,028,414
4,028,4143,414,0193,202,1682,946,1292,897,4482,845,2882,238,4231,934,5301,979,982
   > Total Current Assets 
1,080,068
1,170,744
1,516,256
1,639,451
1,718,026
1,855,579
2,008,990
2,236,804
2,538,313
2,538,3132,236,8042,008,9901,855,5791,718,0261,639,4511,516,2561,170,7441,080,068
       Cash And Cash Equivalents 
92,567
99,795
231,724
147,855
256,629
71,258
67,492
30,488
22,762
22,76230,48867,49271,258256,629147,855231,72499,79592,567
       Short-term Investments 
0
0
310,390
390,000
489,787
915,502
976,078
1,458,209
1,725,339
1,725,3391,458,209976,078915,502489,787390,000310,39000
       Net Receivables 
433,268
418,248
354,603
330,743
273,157
217,687
301,296
194,896
250,664
250,664194,896301,296217,687273,157330,743354,603418,248433,268
       Inventory 
431,231
521,365
485,445
506,568
432,065
449,340
437,672
362,551
405,861
405,861362,551437,672449,340432,065506,568485,445521,365431,231
       Other Current Assets 
120,051
127,288
1,019
121,660
72,056
42,958
40,513
38,234
34,519
34,51938,23440,51342,95872,056121,6601,019127,288120,051
   > Long-term Assets 
0
0
0
857,658
1,176,786
1,090,550
1,193,178
0
0
001,193,1781,090,5501,176,786857,658000
       Property Plant Equipment 
693,786
532,394
494,517
933,009
856,361
796,674
902,897
832,439
846,205
846,205832,439902,897796,674856,361933,009494,517532,394693,786
       Long Term Investments 
165,010
165,010
165,010
165,010
0
0
0
0
0
00000165,010165,010165,010165,010
       Intangible Assets 
6,781
12,762
1
21,272
24,531
24,764
22,279
14,699
38,679
38,67914,69922,27924,76424,53121,272112,7626,781
       Long-term Assets Other 
0
0
0
12,607
0
0
0
0
0
0000012,607000
> Total Liabilities 
1,076,563
1,006,309
870,140
1,015,158
1,037,982
841,672
974,189
970,199
1,233,703
1,233,703970,199974,189841,6721,037,9821,015,158870,1401,006,3091,076,563
   > Total Current Liabilities 
819,496
839,576
754,268
880,566
893,319
683,893
809,788
806,091
1,089,432
1,089,432806,091809,788683,893893,319880,566754,268839,576819,496
       Short-term Debt 
421,352
301,022
202,273
300,251
276,350
4,424
0
4,329
37,657
37,6574,32904,424276,350300,251202,273301,022421,352
       Short Long Term Debt 
421,352
301,022
202,273
311,473
276,350
4,424
0
0
0
0004,424276,350311,473202,273301,022421,352
       Accounts payable 
184,535
180,030
130,173
169,009
317,541
296,929
397,793
0
0
00397,793296,929317,541169,009130,173180,030184,535
       Other Current Liabilities 
69,408
122,234
85,011
46,513
77,164
151,252
112,534
0
0
00112,534151,25277,16446,51385,011122,23469,408
   > Long-term Liabilities 
0
0
0
133,541
144,663
157,779
164,401
0
0
00164,401157,779144,663133,541000
       Long term Debt Total 
0
0
0
0
0
0
14,442
3,947
11,094
11,0943,94714,442000000
       Capital Lease Obligations 
0
0
0
0
0
0
20,475
0
0
0020,475000000
       Long-term Liabilities Other 
0
0
0
44,801
0
0
0
0
0
0000044,801000
> Total Stockholder Equity
903,419
928,221
1,368,283
1,830,130
1,859,466
2,104,457
2,227,979
2,443,820
2,794,711
2,794,7112,443,8202,227,9792,104,4571,859,4661,830,1301,368,283928,221903,419
   Common Stock
57,072
57,072
57,072
57,072
57,072
57,072
57,072
57,072
57,072
57,07257,07257,07257,07257,07257,07257,07257,07257,072
   Retained Earnings 
810,540
835,342
1,311,211
1,773,058
1,802,394
1,989,564
2,086,075
2,304,971
2,628,855
2,628,8552,304,9712,086,0751,989,5641,802,3941,773,0581,311,211835,342810,540
   Capital Surplus 
0
0
0
0
0
31,472
31,472
31,472
31,472
31,47231,47231,47231,47200000
   Treasury Stock000000000
   Other Stockholders Equity 
4,335
4,335
4,335
4,335
4,680
26,349
53,360
50,305
77,312
77,31250,30553,36026,3494,6804,3354,3354,3354,335



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue3,135,114
Cost of Revenue-1,301,341
Gross Profit1,833,7731,833,773
 
Operating Income (+$)
Gross Profit1,833,773
Operating Expense--
Operating Income319,8851,833,773
 
Operating Expense (+$)
Research Development-
Selling General Administrative977,593
Selling And Marketing Expenses-
Operating Expense-977,593
 
Net Interest Income (+$)
Interest Income121,204
Interest Expense--
Net Interest Income-121,204
 
Pretax Income (+$)
Operating Income319,885
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)472,976319,885
EBIT - interestExpense = 0
352,583
352,583
Interest Expense-
Earnings Before Interest and Taxes (ebit)-472,976
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax472,976
Tax Provision-120,393
Net Income From Continuing Ops-352,583
Net Income352,583
Net Income Applicable To Common Shares352,583
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ASRUSA.SW
now

I found you a Golden Cross on the daily chart of ASRUSA.SW.

ASRUSA.SW Daily Candlestick Chart
TRAD.ST
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TRAD.ST.

TRAD.ST Daily Candlestick Chart
MLAIU.NASDAQ
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MLAIU.NASDAQ.

MLAIU.NASDAQ Daily Candlestick Chart
BRKHU.NASDAQ
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BRKHU.NASDAQ.

BRKHU.NASDAQ Daily Candlestick Chart
SPXNTR.INDX
6 minutes ago

I found you a Golden Cross on the daily chart of SPXNTR.INDX.

SPXNTR.INDX Daily Candlestick Chart
SP500NTR.INDX
6 minutes ago

I found you a Golden Cross on the daily chart of SP500NTR.INDX.

SP500NTR.INDX Daily Candlestick Chart
S5TW.INDX
6 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of S5TW.INDX.

S5TW.INDX Daily Candlestick Chart
NDTW.INDX
8 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of NDTW.INDX.

NDTW.INDX Daily Candlestick Chart
AVLD.INDX
12 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of AVLD.INDX.

AVLD.INDX Daily Candlestick Chart
ADVQ.INDX
12 minutes ago

I found you a Death Cross on the daily chart of ADVQ.INDX.

ADVQ.INDX Daily Candlestick Chart
GR1M.GBOND
16 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of GR1M.GBOND.

GR1M.GBOND Daily Candlestick Chart
SBFM.NASDAQ
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBFM.NASDAQ.

SBFM.NASDAQ Daily Candlestick Chart
SANW.NASDAQ
22 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of SANW.NASDAQ.

SANW.NASDAQ Daily Candlestick Chart
RZB.NYSE
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RZB.NYSE.

RZB.NYSE Daily Candlestick Chart
RYU.NYSE ARC
23 minutes ago

I found you a Golden Cross on the daily chart of RYU.NYSE ARC.

RYU.NYSE ARC Daily Candlestick Chart
RRGB.NASDAQ
25 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RRGB.NASDAQ.

RRGB.NASDAQ Daily Candlestick Chart
RNAZ.NASDAQ
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RNAZ.NASDAQ.

RNAZ.NASDAQ Daily Candlestick Chart
SBITOP.INDX
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBITOP.INDX.

SBITOP.INDX Daily Candlestick Chart
BETXT.INDX
30 minutes ago

I found you a Golden Cross on the daily chart of BETXT.INDX.

BETXT.INDX Daily Candlestick Chart
RGF.NASDAQ
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RGF.NASDAQ.

RGF.NASDAQ Daily Candlestick Chart
REED.NASDAQ
33 minutes ago

I found you a Golden Cross on the daily chart of REED.NASDAQ.

REED.NASDAQ Daily Candlestick Chart
RCUS.NYSE
34 minutes ago

I found you a Death Cross on the daily chart of RCUS.NYSE.

RCUS.NYSE Daily Candlestick Chart
RAIN.NASDAQ
38 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of RAIN.NASDAQ.

RAIN.NASDAQ Daily Candlestick Chart
PZZA.NASDAQ
41 minutes ago

I found you a Golden Cross on the daily chart of PZZA.NASDAQ.

PZZA.NASDAQ Daily Candlestick Chart
PTLC.BATS
43 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PTLC.BATS.

PTLC.BATS Daily Candlestick Chart